Ameritas Investment Partners, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,155 shares of MIRM stock, worth $210,658. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,155
Previous 3,843
8.12%
Holding current value
$210,658
Previous $149,000
14.77%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MIRM
# of Institutions
208Shares Held
54MCall Options Held
64.1KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$333 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$232 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$164 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$142 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$132 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.86B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...